Carl Dambkowski Insider Trades & Stock Holdings

Chief Medical Officer · Apogee Therapeutics, Inc. · Latest filing Jun 22, 2026

Carl Dambkowski, Chief Medical Officer at Apogee Therapeutics, Inc. has 3 Form 4 trades on file since Jun 12, 2026 across 2 companies. Open-market activity: 0 purchases ($0) and 3 sales ($5.27M), net -$5.27M. Latest filing: disposed of 26.40K shares of $APGE on Jun 22, 2026 at $132.60.

Trades on file

3

Open-market bought

$0

Open-market sold

$5.27M

Net open-market

-$5.27M

Latest filing

Jun 22, 2026

All insider trades by Carl Dambkowski

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 22, 2026	$APGE	Sell (Open-market sale) 10b5-1	26.40K	$132.60	$3.50M						Chief Medical Officer		Read
Jun 12, 2026	$ORKA	Sell (Open-market sale) 10b5-1	12.58K	$70.11	$882.19K			+22.2%	+21.0%				—
Jun 12, 2026	$ORKA	Sell (Open-market sale) 10b5-1	12.58K	$70.11	$882.19K			+22.2%	+21.0%				—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Carl Dambkowski traded

• $ORKA
• $APGE

Frequently asked questions

Has Carl Dambkowski been buying or selling stock?

Carl Dambkowski has 0 open-market purchases and 3 open-market sales on file, net -$5.27M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Carl Dambkowski's latest insider trade?

disposed of 26.40K shares of $APGE on Jun 22, 2026 at $132.60.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.